Home » Category: 'Innovation' (Page 12)

Innovation

Announcing the 2013 IP Intensive Program

We are pleased to announce details of the 2013 Intellectual Property Law and Technology Intensive Program.  The tremendously successful program is currently in its third year, but it is continuing to grow. We are excited to announce the offering of three brand new placements for 2013, and the return of an excellent placement from the […]

Sparking Innovation With Students: Examining The Student Role From Invention To Commercialization

Sparking Innovation With Students: Examining The Student Role From Invention To Commercialization Conference Chair Prof. Giuseppina D'Agostino  Founder & Director, IP Osgoode Including Keynote Addresses from Sylvain Laporte Commissioner of Patents, Registrar of Trademarks and CEO, Canadian Intellectual Property Office Bill Mantel Assistant Deputy Minister  - Research, Commercialization and Entrepreneurship Division Ontario Ministry of Research […]

Professor Giuseppina D'Agostino on The Agenda with Steve Paikin

IP Osgoode is pleased to announce that our very own  Professor Giuseppina D'Agostino, Founder and Director of IP Osgoode, was featured on last Tuesday's episode of The Agenda with Steve Paikin entitled "Is Innovation History?" The full video is available below.

IP Osgoode Speaker Series: Douglas Pepper

IP Osgoode Speaker Series: "Books Are Dead. Long Live Books" Featuring Douglas Pepper Publisher, Signal/McClelland & Stewart Vice President, Random House of Canada February 13, 12:30pm Osgoode Hall Law School, York University

Electronic Communication: Privacy (In)Action

In the US, a recent bill that included amendments to the Video Privacy Protection Act (VPPA) has caused considerable controversy among privacy advocates. While some are worried about what is in the bill, the bigger problem is what it leaves out.

Live and Let Die: Gene Patenting Plot Thickens as the Patent/Trade Secret Line is Blurred

The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer has been well-documented in the IPilogue (see coverage by Beatrice yesterday as well as previous posts here, here, and here). Now, Myriad is poised to defend their patents at the Supreme Court for a second time, with […]